ArticleBMC cancer2026

Biomarker exploration for immunotherapy plus chemotherapy following resistance to third-generation EGFR-TKIs in lung adenocarcinoma.

Lige Wu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.